Clinical Trials
13 trialsNCT06383598 2026-04-07
PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT05436093 2026-03-04
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT05844306 2025-11-19
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
City of Hope Medical Center
Phase NA Suspended
NCT06755086 2025-01-01
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT06719856 2024-12-27
MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT06720298 2024-12-27
CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT06646952 2024-12-05
CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Recruiting
NCT06429891 2024-08-22
Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT05322512 2023-11-29
Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT02717572 2019-04-05
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Washington University School of Medicine
Phase 1 Completed
NCT02070406 2019-02-28
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT02599194 2019-01-03
18F-FSPG PET/CT for Cancer Patients on Therapy
Stanford University
Phase 2 Completed
NCT00816335 2016-04-04
Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed